To validate the RECOVER PASC score and assess its effectiveness in diagnosing long COVID (LC) in a specialized clinical cohort of patients with neuropsychiatric symptoms.
Key Findings:
The PASC score effectively distinguished between LC patients and controls based on symptomatology, suggesting its utility in clinical settings.
A score of 12 or higher was identified as a cutoff for diagnosing PASC+ individuals.
The study population predominantly consisted of middle-aged females with higher education levels, which may influence the generalizability of the findings.
Interpretation:
The PASC score demonstrates potential as a reliable diagnostic tool for long COVID, but further validation in diverse populations is necessary to ensure its applicability across different demographics.
Limitations:
The study was conducted in a single tertiary referral center, which may limit generalizability to broader populations.
The cohort was imbalanced with more true LC participants than controls, affecting traditional evaluation metrics and potentially skewing results.
Conclusion:
The findings support the use of the PASC score in clinical settings, highlighting the need for ongoing refinement of long COVID diagnostic criteria and further research to validate these findings across diverse populations.
by Alba Azola, Raha M. Dastgheyb, Rebecca Easter, Hannah Parker, Christina Della Penna, Isabel Santiuste, Holly Schultz, Ana Ehrenspeck, Rebecca Veenhuis, Leah H. Rubin
These 10 states make it more practical for physicians to participate in hospital ownership by aligning statutory structure, corporate practice of medicine rules, and population trends.
